Development of hypertension and effects of benazepril hydrochloride in a canine remnant kidney model of chronic renal failure

Journal of Veterinary Medical Science

Volumn 70, Issue 5, 2008, Pages 455-460

  Mishina, Mika ^a   Watanabe, Toshifumi ^a  

^a AZABU UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Benazepril; Canine; Renal ablation; Renal hypertension

Indexed keywords

ALDOSTERONE; ANGIOTENSIN I; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; BENAZEPRIL; BENZAZEPINE DERIVATIVE; RENIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DOG; DOG DISEASE; DRUG EFFECT; FEMALE; HYPERTENSION; MALE;

ALDOSTERONE; ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZAZEPINES; BLOOD PRESSURE; DOG DISEASES; DOGS; FEMALE; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; RENIN;

CANIS FAMILIARIS;

EID: 44849091989     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.70.455     Document Type: Article

References (42)

1. Anderson, L.J. and Fisher, E.W. 1968. The blood pressure in canine interstitial nephritis. Res. Vet. Sci. 9: 304-313.
2. Anderson, S. and Brenner, B.M. 1989. Progressive renal disease: a disorder of adaptation. Q. J. Med. 70: 185-189.
3. Anderson, W.P., Ramsey, D.E. and Tanaka, M. 1990. Development of hypertension from unilateral renal artery stenosis in conscious dogs. Hypertension 16: 441-451.
4. Bell, D.R., Hollingsworth, S.F. and Overbeck, H.W. 1987. Decreased intraocular pressure in dogs with one-kidney, one-wrapped hypertension. Hypertension 10: 152-156.
5. Bidani, A.K., Griffin, K.A., Picken, M. and Lansky, D.M. 1993. Continuous telemetric blood pressure monitoring and glomerular injury in the rat remnant kidney model. Am. J. Physiol. 265: F391-F398.
6. Bodey, A.R. and Michell, A.R. 1996. Epidemiological study of blood pressure in domestic dogs. J. Small Anim. Pract. 37: 116-125.
7. Bovee, K.C., Littman, M.P., Crabtree, B.J. and Aguitrre, G. 1989. Essential hypertension in a dog. J. Am. Vet. Med. Assoc. 195: 81-86.
8. Brenner, B.M., Cooper, M.E., de Zeeuw, D., Keane, W.F., Mitch, W.E., Parving, H.H., Remuzzi, G., Snapinn, S.M., Zhang, Z., Shahinfar, S. and RENAAL Study Investigators. 2001. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New Engl. J. Med. 345: 861-869.
9. Brown, S.A., Brown, C.A., Jacobs, G., Stiles, J., Hendi, R.S. and Wilson, S. 2001. Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency. Am. J. Vet. Res. 62: 375-383.
10. Brown, S.A., Finco, D.R., Brown, C.A., Crowell, W.A., Alva, R., Ericsson, G.E. and Cooper, T. 2003. Evaluation of the effects of inhibition of angiotensin converting enzyme with enalapril in dogs with induced chronic renal insufficiency. Am. J. Vet. Res. 64: 321-327.
11. Brown, S.A., Finco, D.R., Crowell, W.A., Choat, D.C. and Navar, L.G. 1990. Single-nephron adaptations to partial renal ablation in the dog. Am. J. Physiol. 258: F495-F503.
12. Coulter, D.B. and Keith, J.C. 1984. Blood pressures obtained by indirect measurements in conscious dogs. J. Am. Vet. Med. Assoc. 184: 1375-1378.
13. Cowgill, L.D. and Kallet, A.J. 1986. Systemic hypertension. In: Current Veterinary Therapy. 9th ed. (Krik, R. ed). W.B. Sanders Company, Pennsylvania, pp.360-364.
14. Finco, D.R. 2004. Association of systemic hypertension with renal injury in dogs with induced renal failure. J. Vet. Intern. Med. 18: 289-294.
15. Gauer, G.F., Greco, D.S., Getzy, D.M., Cowgill, L.D., Vaden, S.L., Chew, D.J., Polzin, D.J. and Barsanti, J.A. 2000. Effects of enalapril versus placebo as a treatment for canine idiopathic glomerulonephritis. J. Vet. Intern. Med. 14: 526-533.
16. Griffin, K.A., Picken, M. and Bidani, A.K. 1994. Radiotelemetric BP monitoring, antihypertensives and glomeruloprotection in remnant kidney model. Kidney Int. 46: 1010-1018.
17. Guyton, A.C. 1992. Kidney and fluids in pressure regulation. Small volume but large pressure change. Hypertension 19 (Suppl.): I2-I8.
18. Hou, F.F., Zhang, X., Zhang, G.H., Xie, D., Chen, P.Y., Zhang, W.R., Jiang, J.P., Liang, M., Wang, G.B., Liu, Z.R. and Geng, R.W. 2006. Efficacy and safety of benazepril for advanced chronic renal insufficiency. New Engl. J. Med. 354: 189-191.
19. Imanishi, M., Akabane, S., Takamiya, M., Kamura, M., Matsushima, Y. and Kuramochi, M. 1992. Critical degree of renal arterial stenosis that causes hypertension in dogs. J. Vascu. Dis. 10: 833-842.
20. Jensen, J., Henik, R.A., Brownfield, M. and Armstrong, J. 1997. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease. Am. J. Vet. Res. 58: 535-540.
21. Kitagawa, H., Eguchi, T., Kitoh, K., Ohba, Y., Kondo, M., Nakano, M. and Sasaki, Y. 2000. Plasma concentration of an angiotensin-converting enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, after repeated administrations of benazepril in dogs with experimental kidney impairment. J. Vet. Med. Sci. 62: 179-185.
22. Kobayashi, D.L., Peterson, M.E., Graves, T.K., Lesser, M. and Nichols, C.E. 1990. Hypertension in cats with chronic renal failure or hyperthyroidism. J. Vet. Intern. Med. 4: 58-62.
23. Koushanpour, E. and Behnia, R. 1987. Partition of carotid baroreceptor response in two-kidney hypertensive dogs. Am. J. Physiol. 253: R568-R6575.
24. Laragh, J.H. and Pickering, T.G. 1991. Essential hypertension. pp.1909-1936. In: The Kidney (Brenner, BM. and Rector, F.C. eds), W.B. Saunders, Philadelphia.
25. Lefebvre, H.P. and Toutain, P.L. 2004. Angiotensin-converting enzyme inhibitors in the therapy of renal diseases. J. Vet. Pharmacol. Ther. 27: 265-281.
26. Littman, M.P., Robertson, J.L. and Bovee, K.C. 1988. Spontaneous systemic hypertension in dogs: five cases (1981-1983). J. Am. Vet. Med. Assoc. 193: 486-494.
27. Littman, M.P. 1994. Spontaneous systemic hypertension in 24 cats. J. Vet. Intern. Med. 8: 79-86.
28. Meyer, T.W., Anderson, S., Rennke, H.G. and Brenner, B.M. 1987. Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int. 31: 752-759.
29. Mishina, M., Watanabe, T., Fujii, K., Maeda, H., Wakao, Y. and Takahashi, M. 1997. A clinical evaluation of blood pressure through non-invasive measurement using the oscillometric procedure in conscious dogs. J. Vet. Med. Sci. 59: 989-993.
30. Mishina, M., Watanabe, T., Fujii, K., Maeda, H., Wakao, Y. and Takahashi, M. 1998. Non-invasive blood pressure measurements in cats: clinical significance of hypertension associated with chronic renal failure. J. Vet. Med. Sci. 60: 805-808.
31. Mishina, M., Watanabe, T., Matsuoka, S., Shibata, K., Fujii, K., Maeda, H. and Wakao, Y. 1999. Diurnal variations of blood pressure in dogs. J. Vet. Med. Sci. 61: 643-647.
32. Miyazaki, M., Okunishi, H., Okamura, T. and Toda, N. 1987. Elevated vascular angiotensin converting enzyme in chronic two-kidney, one-clip hypertension in the dog. J. Hypertens. 5: 155-160.
33. Papanek, P.E., Bovee, K.C., Skelton, M.M. and Cowley, A.W. 1993. Chronic pressure-natriuresis relationship in dogs with inherited essential hypertension. Am. J. Hypertens. 6: 960-967.
34. Pinto, J.M.B., Kirby, D.A. and Lown, B. 1991. Decrease in repetitive extrasystole threshold during epinephrine infusion is enhanced in conscious dogs with perinephric hypertension. Physiol. Behav. 49: 383-386.
35. Remuzzi, G., Ruggenenti, P. and Perico, N. 2002. Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition. Ann. Intern. Med. 136: 604-615.
36. Ross, J.A. 1992. Hypertension and chronic renal failure. Sem. Vet. Med. Surg. (Small Anim.) 7: 221-226.
37. Spangler, W.L., Gribble, D.H. and Weiser, M.G. 1977. Canine hypertension: a review. J. Am. Vet. Med. Assoc. 170: 95-98.
38. Stiles, J., Polzin, D.J. and Bistner, S. 1994. The prevalence of retinopathy in cats with systemic hypertension and chronic renal failure or hyperthyroidism. J. Am. Anim. Hosp. Assoc. 30: 564-572.
39. Toutain, P.L., Lefebvre, H.P. and Laroute, V. 2002. New insights on effect of kidney insufficiency on disposition of angiotensin-converting enzyme inhibitors: case of enalapril and benazepril in dogs. J. Vet. Pharmacol. Ther. 292: 1094-1103.
40. 14C]- benazepril hydrochloride in rat, dog and baboon. Absorption, distribution, kinetics, biotransformation and excretion. Arzneimittelforschung 39: 62-67.
41. Watanabe, T. and Mishina, M. 2007. Effects of benazepril hydrochloride in cats with experimentally induced or spontaneously occurring chronic renal failure. J. Vet. Med. Sci. 69: 1015-1023.
42. Yu, H.T. 2003. Progression of chronic renal failure. Arch. Intern. Med. 163: 1417-1429.